Patent details

EP3096756 Title: CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

Basic Information

Publication number:
EP3096756
PCT Application Number:
US2015012315
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157029174
PCT Publication Number:
WO2015112642
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
French Title of Invention:
ANTAGONISTES DU RÉCEPTEUR CRF1 POUR LE TRAITEMENT DE L'HYPERPLASIE ADRÉNALE CONGÉNITALE
German Title of Invention:
CRF1-REZEPTOR-ANTAGONISTEN ZUR BEHANDLUNG VON CONGENITALER ADRENALER HYPERPLASIE
SPC Number:

Dates

Filing date:
21/01/2015
Grant date:
12/06/2024
EP Publication Date:
30/11/2016
PCT Publication Date:
30/07/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/06/2024
EP B1 Publication Date:
12/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2024
 
 

Name:
NEUROCRINE BIOSCIENCES, INC.
Address:
12790 El Camino Real, San Diego, CA 92130-1102, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/07/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
GRIGORIADIS, Dimitri, E.
Address:
United States (US)

Priority

1

Priority Number:
201461929941 P
Priority Date:
21/01/2014
Priority Country:
United States (US)

2

Priority Number:
201461981033 P
Priority Date:
17/04/2014
Priority Country:
United States (US)

3

Priority Number:
201462069155 P
Priority Date:
27/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/427; A61K 31/519; A61K 31/4985; A61P 5/38;

Publication

European Patent Bulletin

Issue number:
202424
Publication date:
12/06/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/01/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
18/07/2024 Power Of Attorney 1
19/07/2024 Outgoing Correspondence 1